![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
American Laboratories Incorporated Omaha Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Erysipelas Media, Product code 105, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-330 - Rev 01
This TSE Type CEP, issued on July 05, 2012, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.